We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
NITROFURANTOIN EM (Emcure Pharmaceuticals Pty Ltd)
Product name
NITROFURANTOIN EM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
178 working days (255)
Active ingredients
nitrofurantoin
Registration type
New generic medicine
Indication
NITROFURANTOIN EM (hard capsule) is indicated for the treatment of urinary tract infections such as cystitis and pyelitis when due to susceptible pathogens. Nitrofurantoin does not reach effective levels in plasma and consequently is not indicated for cortical or perinephric abscesses and in cases of prostatitis.